Nicotinic acetylcholine receptors in alzheimer's and Parkinson's disease

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Abstract In the CNS, nicotinic acetylcholine receptors prominent roles in modulating presynaptic and postsynaptic signaling and have been implicated in several CNS disorders including the two most prominent neurodegenerative diseases: Alzheimer's disease and Parkinson's disease. These neurodegenerative diseases affect scores of millions of persons worldwide with their prevalence increasing as human longevity increases. This chapter will provide an overview of Alzheimer's disease and Parkinson's disease, the cholinergic system affected in each disorder, and the types of nicotinic acetylcholine receptors affected during disease progression. Finally, a discussion of therapeutic strategies targeting nicotinic acetylcholine receptors is included based upon the most current preclinical and clinical research.

Original languageEnglish (US)
Title of host publicationNicotinic Receptors
PublisherSpringer New York
Pages383-415
Number of pages33
ISBN (Electronic)9781493911677
ISBN (Print)9781493911660
DOIs
StatePublished - Jan 1 2014

Fingerprint

Nicotinic Receptors
Parkinson Disease
Alzheimer Disease
Neurodegenerative Diseases
Cholinergic Agents
Disease Progression
Research
Therapeutics

Keywords

  • Acetylcholine
  • Basal forebrain cholinergic system
  • Cholinergic
  • Dopamine
  • Hippocampus
  • Neurodegeneration
  • Striatum
  • Substantia nigra

ASJC Scopus subject areas

  • Medicine(all)
  • Neuroscience(all)

Cite this

Nicotinic acetylcholine receptors in alzheimer's and Parkinson's disease. / Dineley, Kelly.

Nicotinic Receptors. Springer New York, 2014. p. 383-415.

Research output: Chapter in Book/Report/Conference proceedingChapter

Dineley, Kelly. / Nicotinic acetylcholine receptors in alzheimer's and Parkinson's disease. Nicotinic Receptors. Springer New York, 2014. pp. 383-415
@inbook{25ee2919029c40838b49af96ec72d266,
title = "Nicotinic acetylcholine receptors in alzheimer's and Parkinson's disease",
abstract = "Abstract In the CNS, nicotinic acetylcholine receptors prominent roles in modulating presynaptic and postsynaptic signaling and have been implicated in several CNS disorders including the two most prominent neurodegenerative diseases: Alzheimer's disease and Parkinson's disease. These neurodegenerative diseases affect scores of millions of persons worldwide with their prevalence increasing as human longevity increases. This chapter will provide an overview of Alzheimer's disease and Parkinson's disease, the cholinergic system affected in each disorder, and the types of nicotinic acetylcholine receptors affected during disease progression. Finally, a discussion of therapeutic strategies targeting nicotinic acetylcholine receptors is included based upon the most current preclinical and clinical research.",
keywords = "Acetylcholine, Basal forebrain cholinergic system, Cholinergic, Dopamine, Hippocampus, Neurodegeneration, Striatum, Substantia nigra",
author = "Kelly Dineley",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/978-1-4939-1167-7_19",
language = "English (US)",
isbn = "9781493911660",
pages = "383--415",
booktitle = "Nicotinic Receptors",
publisher = "Springer New York",

}

TY - CHAP

T1 - Nicotinic acetylcholine receptors in alzheimer's and Parkinson's disease

AU - Dineley, Kelly

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Abstract In the CNS, nicotinic acetylcholine receptors prominent roles in modulating presynaptic and postsynaptic signaling and have been implicated in several CNS disorders including the two most prominent neurodegenerative diseases: Alzheimer's disease and Parkinson's disease. These neurodegenerative diseases affect scores of millions of persons worldwide with their prevalence increasing as human longevity increases. This chapter will provide an overview of Alzheimer's disease and Parkinson's disease, the cholinergic system affected in each disorder, and the types of nicotinic acetylcholine receptors affected during disease progression. Finally, a discussion of therapeutic strategies targeting nicotinic acetylcholine receptors is included based upon the most current preclinical and clinical research.

AB - Abstract In the CNS, nicotinic acetylcholine receptors prominent roles in modulating presynaptic and postsynaptic signaling and have been implicated in several CNS disorders including the two most prominent neurodegenerative diseases: Alzheimer's disease and Parkinson's disease. These neurodegenerative diseases affect scores of millions of persons worldwide with their prevalence increasing as human longevity increases. This chapter will provide an overview of Alzheimer's disease and Parkinson's disease, the cholinergic system affected in each disorder, and the types of nicotinic acetylcholine receptors affected during disease progression. Finally, a discussion of therapeutic strategies targeting nicotinic acetylcholine receptors is included based upon the most current preclinical and clinical research.

KW - Acetylcholine

KW - Basal forebrain cholinergic system

KW - Cholinergic

KW - Dopamine

KW - Hippocampus

KW - Neurodegeneration

KW - Striatum

KW - Substantia nigra

UR - http://www.scopus.com/inward/record.url?scp=85028634557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028634557&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-1167-7_19

DO - 10.1007/978-1-4939-1167-7_19

M3 - Chapter

SN - 9781493911660

SP - 383

EP - 415

BT - Nicotinic Receptors

PB - Springer New York

ER -